InFlectis BioScience Revenue and Competitors
Estimated Revenue & Valuation
- InFlectis BioScience's estimated annual revenue is currently $2.2M per year.
- InFlectis BioScience's estimated revenue per employee is $201,000
Employee Data
- InFlectis BioScience has 11 Employees.
- InFlectis BioScience grew their employee count by -8% last year.
InFlectis BioScience's People
Name | Title | Email/Phone |
---|
InFlectis BioScience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is InFlectis BioScience?
InFlectis BioScience is a private drug discovery company aiming at targeting and modulating interactions between proteins involved in key human pathophysiological processes. The company is developing small molecule drugs that specifically target the Unfolded Protein Response to treat misfolding protein disorders such as neurodegenerative and age-related diseases.
keywords:N/AN/A
Total Funding
11
Number of Employees
$2.2M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
InFlectis BioScience News
2022-03-22 - InFlectis' IFB-088 Earns FDA Orphan Drug Status as ALS ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to InFlectis BioScience's experimental therapy IFB-088 for...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 11 | 0% | N/A |
#2 | N/A | 13 | 8% | N/A |
#3 | $1.7M | 14 | 0% | N/A |
#4 | $1.2M | 14 | -26% | N/A |
#5 | $1.2M | 14 | 0% | N/A |